Results 31 to 40 of about 2,560 (200)

Analysis of the triplet-state kinetics of a photosensitizer for photoimmunotherapy by fluorescence correlation spectroscopy [PDF]

open access: yes, 2021
Herein, we evaluated the intersystem crossing quantum yield (Phi(ISC)) of a silicon phthalocyanine derivatized from IRDye700DX (IR700) which is used as a photosensitizer for photoimmunotherapy (PIT), using fluorescence correlation spectroscopy (FCS). The
Tobita, Seiji   +13 more
core   +1 more source

Targeted Photo-Induced Elimination of Tumor-Associated Macrophages Suppresses Cancer Progression in a Murine Model. [PDF]

open access: yesCancer Sci
This study demonstrates the selective depletion of tumor‐associated macrophages (TAMs) by targeting CSF1R through near‐infrared photoimmunotherapy (NIR‐PIT). Using a combination of anti‐CSF1R Fab‐IR700 conjugates and localized light irradiation, we achieved tumor suppression and durable antitumor immunity without systemic toxicity.
Nakajima K   +6 more
europepmc   +2 more sources

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

open access: yesJournal of Nanobiotechnology, 2022
Background Photoimmunotherapy is one of the most promising strategies in tumor immunotherapies, but targeted delivery of photosensitizers and adjuvants to tumors remains a major challenge.
Hu Chen   +10 more
doaj   +1 more source

Progress of Near-Infrared-Based Medical Imaging and Cancer Cell Suppressors

open access: yesChemosensors, 2022
Diffuse optical tomography, an imaging modality that utilizes near-infrared light, is a new way to assess soft tissue. It provides a non-invasive screening of soft tissue, such as the breast in females and prostate in males, to inspect the existence of ...
Vicky Mudeng   +3 more
doaj   +1 more source

Nasopharyngeal Carcinoma Treated With Photoimmunotherapy

open access: yesCureus, 2023
Photoimmunotherapy is a new treatment modality in which a tumor-targeting monoclonal antibody is combined with a photoactivated dye and a laser is applied to destroy tumor cells. In Japan, insurance reimbursement for this treatment started in January 2021 for unresectable locally advanced or locally recurrent head and neck cancer.
Idogawa, Hiroshi   +4 more
openaire   +2 more sources

Management of anesthesia for photoimmunotherapy

open access: yesJournal of Anaesthesiology Clinical Pharmacology
Sunil Rajan   +3 more
doaj   +3 more sources

Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy

open access: yesiScience, 2023
Summary: Circulating drugs in the peritoneal cavity is an effective strategy for advanced ovarian cancer treatment. Photoimmunotherapy, an emerging modality with potential for the treatment of ovarian cancer, involves near-infrared light activation of ...
Aaron J. Sorrin   +9 more
doaj   +1 more source

Near-Infrared Photoimmunotherapy of Cancer [PDF]

open access: yesAccounts of Chemical Research, 2019
Conspectus This Account is the first comprehensive review article on the newly developed, photochemistry-based cancer therapy near-infrared (NIR) photoimmunotherapy (PIT). NIR-PIT is a molecularly targeted phototherapy for cancer that is based on injecting a conjugate of a near-infrared, water-soluble, silicon-phthalocyanine ...
Hisataka Kobayashi, Peter L. Choyke
openaire   +2 more sources

Supramolecular cancer photoimmunotherapy based on precise peptide self-assembly design

open access: yes, 2022
Combinational photoimmunotherapy (PIT) is considered to be an ideal strategy for the treatment of highly recurrent and metastatic cancer, because it can ablate the primary tumor and provide in situ an autologous tumor vaccine to induce the host immune ...
Yan, Xuehai   +7 more
core   +1 more source

Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumor through cGAS-STING pathway activation

open access: yes, 2023
Source data are provided with the article: Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumor through cGAS-STING pathway activation.
Jin Sun (15370444)
core   +1 more source

Home - About - Disclaimer - Privacy